Search

Suzhou Invotech Scroll Technologies Co., LTD is a high-tech enterprise specializing in the independent research and development, production, and sales of scroll compressors. The company was listed on the ChiNext of the Shenzhen Stock Exchange in December 2022 (Stock Code: 301272). It has long focused on the commercial refrigeration sector, primarily manufacturing medium- to high-pressure-ratio, high-efficiency, and low-noise scroll compressors. Its products are compatible with multiple refrigerants, including R22, R404A, R410A, R290, and R32, and are widely applied in cold-chain warehousing, commercial air conditioning, and heat-pump heating systems. Some low-temperature models operate stably under conditions as low as -35°C, and its flagship products meet China’s Grade 1 energy-efficiency standard. Leveraging an end-to-end technical system covering R&D, design, manufacturing, and testing, the company masters core technologies in scroll compressor structural design, profile optimization, materials and processing techniques, and intelligent control. As of the end of 2023, it had obtained 147 authorized patents (including 32 invention patents) and had led or participated in the formulation of five national and industry standards, including GB/T 37492—2019. The company has established a provincial-level enterprise technology center and the Jiangsu Province Scroll Compressor Engineering Technology Research Center. Its R&D personnel account for over 25% of total staff, and its R&D investment as a percentage of revenue has exceeded 6% annually for the past three years. It has obtained certifications for ISO 9001, ISO 14001, and IATF 16949 quality management systems, as well as domestic and international market access qualifications, including China Energy-Saving Product Certification, CE Certification, and UL Certification. Its core customers include leading domestic refrigeration equipment manufacturers and system integrators. Its business is concentrated primarily in East China, North China, and South China, while also exporting to Southeast Asia, the Middle East, and South America via ODM/OEM arrangements. The company provides customized compressor solutions, joint development, and bulk supply cooperation to both domestic and international clients.

Suzhou Tongsuo Technology Co., Ltd. is a high-tech enterprise specializing in precision mold design and manufacturing, injection molding, and R&D and production of structural components for intelligent terminals. The company positions itself as an integrated solution provider of precision plastic structural components for three major sectors: consumer electronics, automotive lightweighting, and industrial automation. Its core businesses include structural components for consumer electronics—such as smartphone mid-frames, folding-screen hinge brackets, and AR/VR housings—as well as plastic components for automotive lightweighting and precision components for industrial automation. Its products are widely applied by leading domestic smartphone brands and their Tier-1 module manufacturers, and are indirectly exported to Southeast Asian and European markets via the supply chain. The company possesses end-to-end delivery capabilities covering high-precision mold development (including CNC machining, EDM, and mirror-surface polishing), fully electric injection molding (clamping force ranging from 60 to 2,500 tons), surface treatment (IML, PVD, micro-arc oxidation), and assembly and testing. To date, it holds 17 invention patents and 83 utility model patents, with technological expertise focused on multi-slider mold structures, fingerprint-resistant and scratch-resistant composite material processes, and warpage control algorithms for thin-walled parts. It has also participated in the revision of the industry standard “GB/T 39792-2021 Plastic Products—Dimensional Inspection Methods for Precision Injection-Molded Parts.” In terms of certifications, the company is certified under ISO 9001:2015 and IATF 16949:2016 quality management systems and holds a certification for the Quality Management System for Weapons and Equipment. It has been recognized as a Jiangsu Province “Specialized, Refined, Distinctive, and Innovative” (SRDI) SME and as a Suzhou Municipal Intelligent Manufacturing Demonstration Workshop. Leveraging its Provincial Enterprise Technology Center and Municipal Postdoctoral Innovation Practice Base, the company’s R&D investment accounted for 5.2% of its revenue in 2023. Currently, it offers collaborative development, customized production, co-design of molds, and rapid small-batch validation services to OEMs, module manufacturers, and system integrators.

Suzhou Blue Whale Water Treatment Equipment Co., Ltd. is a private enterprise specializing in the integration of industrial and municipal water treatment systems and the research, development, and manufacturing of core equipment, serving the niche market of small- and medium-scale industrial wastewater treatment nationwide with its base in the Yangtze River Delta region. The company’s core business covers the design, production, sales, and installation of water treatment equipment, environmental protection equipment, and automated control systems, while simultaneously offering sales of water treatment chemicals and environmental engineering technical consultation and services. Leveraging proprietary technological pathways—such as the “multi-stage catalytic oxidation + MBR membrane bioreactor” integrated process—the company has established a product system centered on its LJ-W series of intelligent integrated sewage treatment equipment (treatment capacity: 5–500 m³/day), complemented by its self-developed PLC remote monitoring system supporting 4G data transmission and local HMI operation. Its technical capabilities have been recognized by the China National Intellectual Property Administration with two authorized utility model patents (ZL202320892101.6 and ZL202320892102.0), both focusing on structural optimization of integrated units; its quality management system is certified to ISO 9001 (Certificate No.: 00122Q31234R0M, valid until August 2025). Over the past three years, the company has completed multiple representative projects, including the reclaimed water reuse retrofit project at the Wujiang Dyeing & Printing Industrial Park in Suzhou (1,200 m³/day), the advanced treatment of nickel-containing wastewater at a Zhangjiagang electroplating plant (effluent nickel concentration ≤0.1 mg/L), and the pretreatment of high-ammonia-nitrogen wastewater at a Changshu food processing plant (total nitrogen removal rate ≥75%). Its clients span industries such as dyeing and printing, electroplating, food processing, and electronics manufacturing. Adhering to a dual-driver strategy of customized equipment integration and localized technical service, the company provides end-to-end collaborative solutions—from process design and equipment supply to installation/commissioning and operational support—for industrial enterprises, industrial park administrative committees, and EPC general contractors.

Suzhou FMC Plant Protection Co., Ltd. is a high-tech enterprise invested in China by FMC Corporation (USA), specializing in the research and development, manufacturing, and localized application promotion of technical-grade pesticides and formulated products, and committed to providing efficient and sustainable crop protection solutions for Chinese agriculture. The company’s core product portfolio includes insecticides (e.g., chlorfenapyr and cyantraniliprole), fungicides, and herbicides—covering all major categories of plant protection products—and serves key production regions for rice, vegetables, and fruit trees, with particular emphasis on critical application scenarios such as control of the striped stem borer (Chilo suppressalis) and the rice leaf roller (Cnaphalocrocis medinalis), as well as integrated management of pesticide-resistant pests in fruits and vegetables. Leveraging FMC’s global R&D system, the company actively participates in pesticide registration trials, residue standard formulation, and field demonstration projects organized by China’s Ministry of Agriculture and Rural Affairs. It has obtained official registration certificates for multiple core products, including a 200 g/L chlorfenapyr suspension concentrate and a 40% cyantraniliprole water-dispersible granule. Additionally, it maintains regular technical collaboration with the National Agro-Technology Extension and Service Center and provincial plant protection stations. Its production base is located in Suzhou and equipped with GMP-compliant workshops and fully automated, continuous-formulation production lines, strictly adhering to China’s “Emission Standards for Water Pollutants from the Pesticide Industry” (GB 31573–2015) and FMC’s global EHS standards. The company holds a “Pesticide Production License” (Su Nong Yao Sheng Xu [2021] No. 0027), authorizing production of multiple formulations, including hygienic insecticides, insecticides, and fungicides, and has achieved certification under ISO 9001, ISO 14001, and ISO 45001 management systems. Currently, its business focuses exclusively on the mainland China market, with a service network covering major grain and cash-crop production areas across East China, South China, Central China, and Northeast China. It collaborates multidimensionally with channel partners, agricultural service providers, research institutions, and farming entities—including product supply, technology extension, agronomic support, and joint development of end-to-end crop solutions.

Suzhou Amerigen Pharmaceuticals Company Limited is a high-tech enterprise specializing in the research and development, manufacturing, and marketing of dermatological topical medications. Focusing on the treatment of chronic inflammatory skin diseases, the company’s core product pipeline covers indications including psoriasis, atopic dermatitis, and corticosteroid-dependent dermatitis. Its primary products include topical dermatological formulations such as ointments, gels, and solutions. The company has commercially launched “Aifuning® Halometasone Ointment” (National Medical Product Administration Approval No.: H2023XXXX), one of the first dermatological topical corticosteroid generic drugs approved in China under the new registration classification. Its investigational product, “Meijinshu® Tacrolimus–Pimecrolimus Dual-Target Nanogel,” has completed Phase III clinical trials; trial data demonstrated a statistically significant prolongation of recurrence-free period versus monotherapy (p<0.01), with related findings published in the Journal of the European Academy of Dermatology and Venereology (2025). The company operates modern manufacturing facilities compliant with Good Manufacturing Practice (GMP) requirements and holds a “Pharmaceutical Production License” (Category Code: Dh). Its quality management system is certified to ISO 9001:2015, and it has completed process validation and stability studies for multiple investigational products. As of mid-2025, the company holds seven authorized invention patents; its core technologies encompass novel transdermal absorption technologies, microemulsion-based drug delivery systems, and optimized anti-inflammatory and antipruritic compound formulations. A representative patent is “A Synergistic Sustained-Release Gel Containing Halometasone and Tacrolimus and Preparation Method Thereof” (Patent No.: ZL202010XXXXXX.X). Leveraging local CDMO partners in Suzhou, the company has established an integrated layout covering active pharmaceutical ingredients (APIs) and finished dosage forms. Its current market coverage is concentrated in Grade II and above hospitals and specialized dermatology chain institutions in the East China region; it has not yet initiated overseas regulatory registration or export activities. The company offers clinical need-driven R&D collaboration, GMP-compliant manufacturing support, and professional promotion services for dermatological products to healthcare institutions, academic platforms, CDMO partners, and regional distribution channels.

Matsuki Tomishima (Dalian) Fine Chemical Co., Ltd. is a wholly foreign-owned enterprise established in China by Japan’s Matsuki Tomishima Co., Ltd. The company positions itself as a provider of high-end functional chemical solutions, focusing on four key application areas: electronic materials; auxiliary agents for new-energy batteries; eco-friendly textile printing and dyeing auxiliaries; and industrial cleaning agents. Its core business encompasses research & development, manufacturing, sales, and technical services for fine chemical products—including surfactants, functional auxiliaries, specialty additives for electronic chemicals, and water treatment chemicals—serving niche markets such as semiconductor packaging, lithium-ion battery electrolyte modification, synthetic fiber printing and dyeing, and metal surface treatment. Leveraging its Dalian Municipal Enterprise Technology Center, the company masters core technologies including the “synthesis process for high-purity amphoteric surfactants” and the “low-temperature, high-efficiency defoaming component compounding technology.” It holds six authorized Chinese invention patents and four utility model patents, all currently valid. In terms of certifications, the company is certified under ISO 9001:2015 (Quality Management Systems), ISO 14001:2015 (Environmental Management Systems), and IATF 16949:2016 (Automotive Supply Chain Management Systems); it also holds the “Level-3 Standardized Enterprise Certificate for Safety Production (Chemical Industry)” and the “People’s Republic of China Industrial Product Production License.” Notable implementations include custom-developing and mass-producing electrolyte dispersion stabilizers for leading power battery manufacturers; participating in drafting the industry standard “Evaluation Specification for Green Design Products: Textile Printing and Dyeing Auxiliaries” (T/CNTAC 122–2023); and supplying UL-certified halogen-free cleaning agent solutions to three local Dalian-based semiconductor packaging and testing enterprises. Currently, the company’s business covers the East China, South China, and Northeast China regions, with customers concentrated in the electronic materials, new-energy, and textile printing & dyeing industries. It offers diversified collaboration models—including joint R&D, customized product development, technical co-upgrading, and collaborative standards development—with upstream and downstream partners across the industrial chain.

Sichuan Yaxi Technology Co., Ltd. is a medium- and small-sized information technology service enterprise headquartered in Sichuan Province, focusing on intelligent upgrading of transportation infrastructure. Its core businesses include software development, information system integration services, information technology consulting, data processing and storage support, network and information security software development, intelligent control system integration, and industrial internet data services. The company’s technological approach centers on AI-based visual analysis, edge sensing, and industry-specific scenario data modeling, with a primary focus on intelligent transportation. It has developed mature application capabilities in scenarios such as operation and maintenance of electromechanical systems on expressways, tunnel safety monitoring, road network event identification, and dynamic meteorological risk assessment. The company holds 12 software copyrights, including “Tunnel Abnormal Behavior Recognition System Based on Deep Learning V1.0” and “Dynamic Meteorological Risk Assessment Software for Expressways V2.2”; its related algorithms and platforms have been validated in real-world projects. The “Yaxi Expressway Intelligent Maintenance Monitoring Platform,” jointly constructed by the company with a research institution under the Sichuan Provincial Department of Transport, is a pilot project featuring edge computing device connectivity and multi-source heterogeneous data fusion analysis; it was reported by China Transport News in 2023. Between 2022 and 2024, the company won seven bidding projects listed on the China Tendering and Bidding Public Service Platform and the Sichuan Government Procurement Network, with a total contract value of approximately RMB 18.6 million. Its primary clients are expressway operating companies and municipal- or prefectural-level transport bureaus within Sichuan Province, and its business covers the western Sichuan and Panxi regions. The company continuously disseminates industry solutions and application cases via its WeChat official account “Sichuan Yaxi Technology”; no publicly recorded cross-provincial or overseas business activities have been identified. Targeting transportation regulatory authorities, expressway operating entities, system integrators, and equipment manufacturers, the company offers collaborative models including customized software development, intelligent monitoring platform construction, embedded deployment of AI algorithms, data governance, and operational support.

Sichuan Taihuatang Pharmaceutical Co., Ltd. is a modern pharmaceutical enterprise established in 2003, specializing in the research and development, manufacturing, and marketing of traditional Chinese patent medicines, chemical drugs, and health food products. The company possesses Good Manufacturing Practice (GMP)-compliant production capabilities for multiple dosage forms, including tablets, hard capsules, granules, pills (water pills and honey pills), oral liquids, syrups, and mixtures. It holds the “Pharmaceutical Production License” (No. Chuan 20160090) and passed the conformity inspection for the new version of the Pharmaceutical GMP standards in 2021. To date, the company has obtained approval for over 30 pharmaceutical products bearing the national drug approval numbers Z or H, including representative products such as “Shenqi Jiangtang Granules” (Z20025027), “Fuyankang Tablets” (Z20025028), and “Compound Danshen Tablets” (Z51021342). Several of its products have been included in both the “National Essential Medicines List” and provincial medical insurance catalogs. The company has established a provincial-level enterprise technology center and holds five invention patents and three utility model patents; its core technologies cover standardized preparation of traditional Chinese medicine (TCM) extracts, simultaneous quality control of multiple components, and optimization of sustained-release formulation processes. Its quality management system remains consistently stable: the pass rate for factory release testing of major products remained at 100% from 2021 to 2023, and stability study data comply with the requirements stipulated in the Chinese Pharmacopoeia (2020 Edition). The company has obtained certification for both the ISO 9001:2015 Quality Management System and the ISO 14001:2015 Environmental Management System; certain production lines meet relevant requirements outlined in the European Union’s GMP guidelines. Its business operations span all 30 provinces (autonomous regions and municipalities) across China, primarily serving grassroots healthcare institutions and retail pharmacies. The company maintains long-term cooperative relationships with major pharmaceutical distribution enterprises, including China Resources Pharmaceuticals, JiuZhouTong, and Chongqing Pharmaceutical Group. We sincerely invite pragmatic collaboration in areas including joint pharmaceutical R&D, contract manufacturing (CMO/CDMO), channel co-construction, promotion of products listed in medical insurance catalogs, and technical cooperation on TCM standardization.

SKF (Dalian) Bearings and Precision Technology Products Co., Ltd. is a wholly owned subsidiary of the Swedish SKF Group in China and serves as one of SKF’s key R&D, manufacturing, and service bases in the country. The company focuses on providing high-end bearings, precision components, and intelligent condition monitoring solutions. Its core business encompasses spherical roller bearings, cylindrical roller bearings, split bearings, customized special-purpose bearings, as well as SKF Enlight IQ series condition monitoring sensors and edge computing modules. These products are widely applied in heavy-duty and high-reliability sectors—including wind power, metallurgy, mining, cement production, papermaking, rail transportation, and industrial automation. Leveraging its Dalian factory, which completed intelligent upgrading in 2018, the company has established a domestically leading full-lifecycle bearing testing center and a condition monitoring technology R&D laboratory, possessing core capabilities in vibration analysis, thermal simulation, and material failure modeling. As of the end of 2024, it has participated in over 30 authorized Chinese invention patents covering areas such as optimized sealing structures, low-friction cage designs, and integrated intelligent lubrication systems. The company holds multiple international management system certifications, including ISO 9001, ISO 14001, ISO 45001, and IATF 16949 (applicable to specific production lines); it has led or participated in drafting national and industry standards, including GB/T 27954—2022 and JB/T 14370—2023. Several of its wind turbine main shaft bearings and yaw/pitch bearings have passed 20-year operational life validation by leading OEMs—including Goldwind, Envision Energy, and Mingyang Smart Energy—and have entered mass production and installation. Its business covers all 31 provincial-level administrative regions across China and provides localized technical support and rapid-response services to customers in Southeast Asia, the Middle East, and South America. In 2023, it was awarded the title “Liaoning Provincial Green Factory,” and in 2024, it was selected by the Ministry of Industry and Information Technology (MIIT) as an “Intelligent Manufacturing Demonstration Factory Candidate.” It offers in-depth collaboration with equipment manufacturers, end users, and system integrators across areas including joint product R&D, customized bearing supply, deployment of intelligent condition monitoring systems, full-lifecycle technical services, and co-development of standards.